The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof wherein G is (II) or (III) R1, R2 and R3 are as described herein pharmaceutical compositions thereof and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.